Results 131 to 140 of about 168,260 (202)

Tumor-Infiltrating Lymphocytes and Tumor Budding: Emerging Prognostic Markers in Breast Cancer. [PDF]

Cureus
Rastogi N, Ghosh S, Sameer P, Mishra D, Guha P.   +4 more
europepmc   +1 more source

Malignant Melanoma as a Rare Cause of Penile Cancer: A Case Report. [PDF]

Cureus
Guarda D, Bascuñán G, Márquez P, Mendez-Villanueva DI.   +3 more
europepmc   +1 more source

Prognostic relevance of increased tumor-infiltrating lymphocytes in residual TNBC following neoadjuvant chemotherapy. [PDF]

BMC Cancer
da Costa NC, Fernandes ACP, Damin APS.
europepmc   +1 more source

Stromal tumor-associated eosinophils predict therapeutic resistance and survival in locally advanced tongue squamous cell carcinoma after neoadjuvant therapy. [PDF]

Ther Adv Med Oncol
Huang J, Chen Y, Yuan L, Xian X, Shen X, Qin W, Zeng J, Hu W.   +7 more
europepmc   +1 more source

Prostate-Specific Membrane Antigen (PSMA): A Potential Theranostic Biomarker in Breast Cancer. [PDF]

Biomedicines
Virga A, Foca F, Cortecchia S, Poli F, Caroli P, Matteucci F, Maltoni R, Mazza M, Nicolini F, Ulivi P, Paganelli G, Puccetti M, Bravaccini S.   +12 more
europepmc   +1 more source

Correspondence on 'Deep learning-based quantification of tumor-infiltrating lymphocytes as a prognostic indicator in nasopharyngeal carcinoma: multicohort findings'. [PDF]

ESMO Open
Liu X, Zhang B.
europepmc   +1 more source

Non-Genetically Modified Adoptive Cell Therapies for Solid Tumors: Current Landscape and Future Challenges. [PDF]

Cancer Immunol Immunother
Luo Q, Jiang W, Xie Y, Dai Z, Zhu J, Du Y, Tao X, Lei Z, Chu X, Wang B, Fu G.   +10 more
europepmc   +1 more source

Response to correspondence on 'Deep learning-based quantification of tumor-infiltrating lymphocytes as a prognostic indicator in nasopharyngeal carcinoma: multicohort findings'. [PDF]

ESMO Open
Lu T, Li J.
europepmc   +1 more source

Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patterns. [PDF]

Cancer Immunol Immunother
Quatannens D, Verhoeven Y, van der Heijden S, Peeters D, Claes J, Hermans C, Lambrechts H, Zwaenepoel K, van Dam P, Peeters M, Prenen H, Koljenovic S, De Waele J, Faes C, Lardon F, Roeyen G, Smits E, Van Audenaerde J.   +17 more
europepmc   +1 more source